Psychiatric profile in rubinstein-taybi syndrome

Psychopathology

Volumn 43, Issue 1, 2009, Pages 63-68

  Verhoeven, W M A ^a,b   Tuinier, S ^a   Kuijpers, H J H ^a   Egger, J I M ^a,c   Brunner, H G ^d  

^a VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Behavioural disorder; Genetic syndrome; Intellectual disability; Psychopathology; Rubinstein Taybi

Indexed keywords

CREBBP PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, HUMAN;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 22; CHROMOSOME DELETION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; GENETICS; HUMAN; IMPULSE CONTROL DISORDER; MALE; MENTAL DEFICIENCY; NEUROPSYCHOLOGICAL TEST; NUCLEOTIDE SEQUENCE; PHENOTYPE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; RUBINSTEIN SYNDROME; STATISTICS;

ADULT; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; CREB-BINDING PROTEIN; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; E1A-ASSOCIATED P300 PROTEIN; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MENTAL RETARDATION; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; PSYCHOMETRICS; RUBINSTEIN-TAYBI SYNDROME;

EID: 70450159836     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000260045     Document Type: Article

References (36)

1. Rubinstein JH, Taybi H: Broad thumbs and toes and facial abnormalities. Am J Dis Child 1963; 105: 588-608.
2. Hennekam RCM: Rubinstein-Taybi syndrome; in Cassidy SB, Allanson JE (ed): Management of Genetic Syndromes. New Jersey, Wiley-Liss, 2005, pp 479-487.
3. Hennekam RCM, Stevens CA, Van de Kamp JJP: Etiology and recurrence risk in Rubinstein- Taybi syndrome. Am J Med Genet 1990; 6: 56-64.
4. Cantani A, Gagliesi D: Rubinstein-Taybi syndrome: review of 732 cases and analysis of the typical traits. Eur Rev Med Pharmacol Sci 1998; 2: 81-87.
5. Rubinstein JH: Broad thumb-hallux (Rubinstein- Taybi) syndrome 1957-1988. Am J Med Genet 1990; 6: 3-16.
6. Miller RW, Rubinstein JH: Tumors in Rubinstein- Taybi syndrome. Am J Med Genet 1995; 56: 112-115.
7. Nuri Sener R: Rubinstein-Taybi syndrome: cranial MR imaging findings. Comput Med Imaging Graph 1995; 19: 417-418.
8. Hennekam RCM, Tilanus M, Hamel BCJ, Voshart-Van Heeren H, Mariman ECM, Van Beersum SE, Van den Boogaard MJH, Breunings M: Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects. Am J Hum Genet 1993; 52: 255-262.
9. Roelfsema JH, White SJ, Ariyürek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, Den Dunnen JT, Van Ommen GJB, Breuning MH, Hennekam RC, Peters DJM: Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 2005; 76: 572-580.
10. Hallam TM, Bourtchouladze R: Rubinstein- Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction. Cell Mol Life Sci 2006; 63: 1725-1735.
11. Bartholdi D, Roelfsema JH, Papadia F, Breuning MH, Niedrist D, Hennekam RC, Schinzel A, Peters JM: Genetic heterogeneity in Rubinstein-Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300. J Med Genet 2007; 44: 327-333.
12. Bartsch O, Schmidt S, Richter M, Morlot S, Seemanová E, Wiebe G, Rasi S: DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein- Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet 2005; 117: 485-493.
13. Roelfsema JH, Peters DJ: Rubinstein-Taybi syndrome: clinical and molecular overview. Expert Rev Mol Med 2007; 9: 1-16.
14. Asberg M, Schalling D: Construction of a new psychiatric rating instrument; the Comprehensive Psychopathological Rating Scale (CPRS). Prog Neuropsychopharmacol 1979; 3: 405-412.
15. Van Minnen A, Savelsberg PM, Hoogduin KA: A Dutch version of the psychopathology inventory for mentally retarded adults (PIMRA). Res Dev Disabil 1994; 15: 269-278
16. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic criteria for research. World Health Organization, Geneva, 1993.
17. Verhoeven WMA, Tuinier S: Serotonin uptake inhibitors in patients with intellectual disabilities; in Shirley AC (ed): Trends in Serotonin Uptake Inhibitor Research. New York, Nova Science, 2005, pp 157-172.
18. Gotts EE, Liemohn WP: Behavorial characteristics of three children with the broad thumb-hallux (Rubinstein-Taybi) syndrome. Biol Psychiatry 1977; 12: 413-423.
19. Baxter G, Beer J: Rubinstein-Taybi syndrome. Psychol Rep 1992; 70: 451-456.
20. Levitas AS, Reid CS: Rubinstein Taybi syndrome and psychiatric disorders. J Intellect Disabil Res 1998; 42: 284-292.
21. Levitas AS, Reid CS: Rubinstein Taybi syndrome. Ment Health Asp Develop Disabil 2003; 6: 130-134.
22. Hennekam RCM, Baselier ACA, Beyaert E, Bos A, Blok JB, Jansma HBM, Thorbecke- Nilsen VV, Veerman H: Psychological and speech studies in Rubinstein-Taybi syndrome. Am J Ment Retard 1992: 96; 645-660.
23. Hellings JA, Hossain S, Martin JK, Baratang RR: Psychopathology, GABA, and the Rubinstein- Taybi syndrome: a review and case study. Am J Med Genet 2002; 114: 190-195.
24. Stevens CA, Carey JC, Blackburn BL: Rubinstein- Taybi syndrome: a natural history study. Am J Med Genet 1990; 6: 30-37.
25. Boer H, Langton J, Clarke D: Development and behaviour in genetic syndromes: Rubinstein- Taybi syndrome. J Appl Res Int Dis 1999; 12; 302-307.
26. King BH, DeAntonio C, McCracken JT, Forness SR, Ackerland V: Psychiatric consultation in severe and profound mental retardation. Am J Psychiatry 1994; 151: 1802-1808.
27. Bodfish JW, Crawford TW, Powell SB, Parker DE, Golden RN, Lewis M: Compulsions in adults with mental retardation: prevalence, phenomenology and comorbidity with stereotypy and self-injury. Am J Mental Retard 1995; 100: 183-192.
28. Gualtieri CT: Psychiatric disorders in mentally retarded people; in Gualtieri CT (ed): Brain Injury and Mental Retardation: Psychopharmacology and Neuropsychiatry. New York, Lippincott Williams & Wilkins, 2002, pp 165-173.
29. Davis LL, Ryan W, Adinoff B, Petty F: Comprehensive review of the psychiatric uses of valproate. J Clin Psychopharmacol 2000; 20(suppl 1):1-17.
30. Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/ Mental Retardation. London, Royal College of Psychiatrists 2001.
31. Kendell R, Jablensky A: Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003; 160: 4-12.
32. Salvador-Carulla L, Bertelli M: Mental Retardation or intellectual disability: time for a conceptual change. Psychopathology 2008; 41: 10-16.
33. Verhoeven WMA, Tuinier S, van der Burgt I: Top-down or bottom-up: contrasting perspectives on psychiatric diagnoses. Biol Targets Ther 2008; 2: 409-417.
34. Verhoeven WMA, Egger J, Tuinier S: Thoughts on the behavioural phenotypes in Prader-Willi syndrome and velo-cardio-facial syndrome: a novel approach. Acta Neuropsychiatr 2007; 19: 244-250.
35. Verhoeven WMA, Tuinier S: Two steps forward, one step back: paradigmatic changes in psychiatry. J Neural Transm 2001; 108: 617-627.
36. Green MF: Stimulating the development of drug treatments to improve cognition in schizophrenia. Annu Rev Clin Psychol 2007; 3: 159-180.